Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Haber, Daniel A

Class:Id	Person:5250757
_displayName	Haber, Daniel A
_timestamp	2014-01-30 22:13:50
created	[InstanceEdit:5250758] Rothfels, K, 2014-01-30
firstname	Daniel A
initial	DA
surname	Haber
(author)	[LiteratureReference:5251473] An X chromosome gene, WTX, is commonly inactivated in Wilms tumor [LiteratureReference:5632390] REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species [LiteratureReference:6799047] Elevated CRAF as a potential mechanism of acquired resistance to BRAF inhibition in melanoma [LiteratureReference:8876008] Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752 [LiteratureReference:9670568] Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors [LiteratureReference:9704369] A recurrent mutation in PALB2 in Finnish cancer families
[Change default viewing format]

No pathways have been reviewed or authored by Haber, Daniel A (5250757)